Your browser doesn't support javascript.
loading
Impact of N6-methyladenosine (m6A) modification on immunity.
Elsabbagh, Raghda A; Rady, Mona; Watzl, Carsten; Abou-Aisha, Khaled; Gad, Mohamed Z.
Afiliação
  • Elsabbagh RA; Biochemistry Department, Faculty of Pharmacy and Biotechnology, The German University in Cairo, Cairo, Egypt.
  • Rady M; Microbiology, Immunology and Biotechnology Department, Faculty of Pharmacy and Biotechnology, The German University in Cairo, Cairo, Egypt. mona.rady@guc.edu.eg.
  • Watzl C; Faculty of Biotechnology, German International University, New Administrative Capital, Cairo, Egypt. mona.rady@guc.edu.eg.
  • Abou-Aisha K; Department of Immunology, Leibniz Research Centre for Working Environment and Human Factors (IfADo)-TU Dortmund, Dortmund, Germany.
  • Gad MZ; Microbiology, Immunology and Biotechnology Department, Faculty of Pharmacy and Biotechnology, The German University in Cairo, Cairo, Egypt.
Cell Commun Signal ; 20(1): 140, 2022 09 09.
Article em En | MEDLINE | ID: mdl-36085064
N6-methyl-adenosine (m6A) is the most prevalent modification on mRNAs and long noncoding RNAs (lnRNAs) in higher eukaryotes. Modulation of m6A relies on m6A writers, erasers and readers. m6A modification contributes to diverse fundamental biological functions at the molecular, cellular, and physiological levels. The dysregulation of m6A modification has been implicated in various human diseases. Thus, m6A modification has now become a research hotspot for its potential therapeutic applications in the treatment of various cancers and diseases. The immune system is essential to provide defense against infections and cancers. This review summarizes the current knowledge about the roles of m6A in regulating immune cell functions and immune responses. Video abstract.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Metiltransferases / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Metiltransferases / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article